Skip to main content

Table 2 Prevalence of metabolic syndrome

From: Prevalence and factors associated with nonalcoholic fatty liver disease in shanghai work-units

  

Male

  

Female

  

Total

 
 

NAFLD (n(%))

Non NAFLD (n(%))

P

NAFLD (n(%))

Non NAFLD (n(%))

P

NAFLD (n(%))

Non NAFLD (n(%))

P

obesity

1279(29.53)

419(9.68)

.000

326(11.55)

167(5.92)

.000

1605(22.44)

586(8.19)

.000

Abdominal obesity

966(22.31)

338(7.81)

.000

316(11.20)

206(7.30)

.000

1282(17.93)

544(7.61)

.000

BP>130/85 or HBP

1012(23.37)

498(11.50)

.000

321(11.37)

302(10.70)

.000

1333(18.64)

800(11.18)

.000

dyslipidemia

1137(26.26)

396(9.15)

.000

283(10.03)

229(8.11)

.000

1420(19.85)

625(8.74)

.000

FPG>5.6 or 2-DM

420(9.70)

182(4.20)

.000

130(4.61)

83(2.94)

.000

550(7.69)

265(371)

.000

  1. Metobolic syndrome: (1) Obesty: Body mass index ≥25kg/m2; abdominal obesity: ≥90cm(male), ≥80cm(female); (2) Blood pressure (BP)≥130/85mmHg Or hypertension (HBP); (3) Dyslipidemia: Triglycerides (TG)≥1.7mmol/L, and/or High Density Lipoprotein cholesterol (HDL)≤1.03mmol/L, (male) <1.29mmol/L (female); (4) Fasting blood glucose (FPG)≥5.6 mmol/L Or type 2 diabetes (2-DM).